pharmaceutical pricing trends – The Milli Chronicle

Friday, October 24, 2025

Latest:

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle October 23, 2025October 23, 2025 drug cost savings analysis, drug price transparency, drug pricing and patient access., fair medicine pricing, health benefit price benchmark, healthcare affordability America, healthcare policy reform, ICER drug cost analysis, ICER economic review, ICER report 2025, ICER value-based pricing model, Medicaid drug costs, Pfizer drug pricing deal, pharmaceutical pricing benchmark, pharmaceutical pricing trends, prescription drug affordability, prescription drug cost reduction, sustainable healthcare system, U.S. drug price alignment, U.S. drug pricing reform, U.S. healthcare efficiency, U.S. healthcare savings, U.S. patient access to medicine, U.S. pharmaceutical innovation, value-based healthcare pricing

Study Highlights $1.5 Billion Savings in U.S. Drug Costs

ICER study shows aligning U.S. drug prices with health value benchmarks could save $1.5 billion and improve patient access. A